"If the mechanism was sound for liver cancer, then some activity - any activity - would have been reported for lung cancer."
Remember, liver was a monotherapy trial. And, this lung trial was a combo w/ Taxotere. They do mention that there are 9 patients on just PI-88 that have interesting signs worth looking into further.
"The future of PI-88 as a viable drug for multiple conditions is now dead."
Wrong again. There are other trials on-going - Melanoma, Multiple Myeloma, Prostate.....but you knew this already, right?
And, if they decide to pursue a lung monotherapy trial.........???
Time for you to go on lunch break....isn't your boss asking you to clock out yet?
PGL Price at posting:
0.0¢ Sentiment: Buy Disclosure: Not Held